Open Access. Powered by Scholars. Published by Universities.®
Social and Behavioral Sciences Commons™
Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 3 of 3
Full-Text Articles in Social and Behavioral Sciences
Men's Perspectives On The Impact Of Female-Directed Cash Transfers On Gender Relations: Findings From The Hptn 068 Qualitative Study, Makhosazane Nomhle Khoza, Sinead Delany-Moretlwe, Fiona Scorgie, Jennifer Hove, Amanda Selin, John Imrie, Rhian Twine, Kathleen Kahn, Audrey Pettifor, Catherine L. Mac Phail
Men's Perspectives On The Impact Of Female-Directed Cash Transfers On Gender Relations: Findings From The Hptn 068 Qualitative Study, Makhosazane Nomhle Khoza, Sinead Delany-Moretlwe, Fiona Scorgie, Jennifer Hove, Amanda Selin, John Imrie, Rhian Twine, Kathleen Kahn, Audrey Pettifor, Catherine L. Mac Phail
Faculty of Social Sciences - Papers (Archive)
HIV is an inherently gendered disease in eastern and southern Africa, not only because more women than men are infected, but also because socially constructed gender norms work to increase women's HIV-infection risk. The provision of cash transfers to young women alone in such a context adds another dimension to already existing complex social relations where patriarchal values are entrenched, gender inequality is the norm, and violence against women and girls is pervasive. It raises concerns about complicating young women's relationships with their male partners or possibly even setting them up for more violence. In our attempt to understand how …
Effect Of Cannabis Use In People With Chronic Non-Cancer Pain Prescribed Opioids: Findings From A 4-Year Prospective Cohort Study, Gabrielle Campbell, Wayne Hall, Amy Peacock, Nicholas Lintzeris, Raimondo Bruno, Briony K. Larance, Suzanne Nielsen, Milton Cohen, Gary Chan, Richard P. Mattick, Fiona Blyth, Marian D. Shanahan, Timothy Dobbins, Michael P. Farrell, Louisa Degenhardt
Effect Of Cannabis Use In People With Chronic Non-Cancer Pain Prescribed Opioids: Findings From A 4-Year Prospective Cohort Study, Gabrielle Campbell, Wayne Hall, Amy Peacock, Nicholas Lintzeris, Raimondo Bruno, Briony K. Larance, Suzanne Nielsen, Milton Cohen, Gary Chan, Richard P. Mattick, Fiona Blyth, Marian D. Shanahan, Timothy Dobbins, Michael P. Farrell, Louisa Degenhardt
Faculty of Social Sciences - Papers (Archive)
Background Interest in the use of cannabis and cannabinoids to treat chronic non-cancer pain is increasing, because of their potential to reduce opioid dose requirements. We aimed to investigate cannabis use in people living with chronic non-cancer pain who had been prescribed opioids, including their reasons for use and perceived effectiveness of cannabis; associations between amount of cannabis use and pain, mental health, and opioid use; the effect of cannabis use on pain severity and interference over time; and potential opioid-sparing effects of cannabis. Methods The Pain and Opioids IN Treatment study is a prospective, national, observational cohort of people …
Opioid Use And Harms Associated With A Sustained-Release Tapentadol Formulation: A Postmarketing Study Protocol, Amy Peacock, Briony K. Larance, Michael P. Farrell, Rose Cairns, Nicholas A. Buckley, Louisa Degenhardt
Opioid Use And Harms Associated With A Sustained-Release Tapentadol Formulation: A Postmarketing Study Protocol, Amy Peacock, Briony K. Larance, Michael P. Farrell, Rose Cairns, Nicholas A. Buckley, Louisa Degenhardt
Faculty of Social Sciences - Papers (Archive)
Introduction It has been argued that tapentadol may pharmacologically have lower abuse potential than other pharmaceutical opioids currently available. However, there has been no comprehensive triangulation of data regarding use and harms associated with this formulation. A sustained-release formulation (SRF) of tapentadol (Palexia) was released in Australia in 2011 and listed for public subsidy in 2013. We summarise here the methods of a postmarketing study which will measure postintroduction: (1) population level availability, (2) extramedical use and diversion, (3) attractiveness for extramedical use and (4) associated harms, of tapentadol compared against other pharmaceutical opioids. Methods and analysis We evaluated key …